Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres

被引:21
|
作者
Marin, B. [1 ,2 ,3 ]
Beghi, E. [4 ]
Vial, C. [5 ]
Bernard, E. [5 ]
Lautrette, G. [6 ]
Clavelou, P. [7 ]
Guy, N. [7 ]
Lemasson, G. [8 ]
Debruxelles, S. [8 ]
Cintas, P. [9 ]
Antoine, J. C. [10 ]
Camdessanche, J. P. [10 ]
Logroscino, G. [11 ,12 ]
Preux, P. M. [1 ,2 ,3 ]
Couratier, P. [1 ,2 ,6 ]
机构
[1] INSERM, U1094, Trop Neuroepidemiol, Limoges, France
[2] Univ Limoges, UMR S 1094, Inst Neuroepidemiol & Trop Neurol, Trop Neuroepidemiol,CNRS FR GEIST 3503, F-87000 Limoges, France
[3] CHU Limoges, Ctr Epidemiol Biostat & Methodol Rech, Limoges, France
[4] IRCCS Ist Ric Farmacol Mario Negri, Dipartimento Neurosci, Lab Malattie Neurol, Milan, Italy
[5] CHU Lyon, Hop Neurol P Wertheimer, Electromyog & Pathol Neuromuscularies, Lyon, France
[6] CHU Limoges, Serv Neurol, Ctr Expert SLA, Limoges, France
[7] CHU Clermont Ferrand, Hop Gabriel Montpied, Serv Neurol, Ctr Expert SLA, Clermont Ferrand, France
[8] CHU Pellegrin, Serv Neurol, Ctr Expert SLA, Bordeaux, France
[9] CHU Toulouse Purpan, Ctr Expert SLA, Unite Neurophysiol Clin, Toulouse, France
[10] CHU St Etienne, Hop Nord, Serv Neurol, Ctr Expert SLA, St Etienne, France
[11] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy
[12] Univ Bari Aldo Moro, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Pia Fdn Cardinale G Panico, Lecce, Italy
关键词
access and evaluation; amyotrophic lateral sclerosis; clinical audit; healthcare quality; practice guideline; QUALITY STANDARDS SUBCOMMITTEE; PRACTICE PARAMETER UPDATE; AMERICAN ACADEMY; PALLIATIVE CARE; MANAGEMENT; LESSONS; TIME;
D O I
10.1111/ene.12941
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purposeOur objective was to evaluate the extent to which the 2005 recommendations of the European Federation of Neurological Sciences (EFNS) on the multidisciplinary management of amyotrophic lateral sclerosis (ALS) are followed in clinical practice. MethodsThis was a multicentre observational study involving six French ALS referral centres receiving prevalent and incident cases. Recommendations were translated into ad hoc questions referring to key aspects of management, and their application was evaluated by a clinical research assistant who independently examined the medical charts (MCs). When necessary, an independent board-certified neurologist answered the questions based on examination of the MC and interview of the caring neurologist. Questions regarding diagnosis and communication were put to patients in a self-administered questionnaire. ResultsIn all, 376 patients [176 incident, 200 prevalent cases; median age at diagnosis 62.8 years (interquartile range 55.7-72.3); sex ratio 1.37; 27.3% bulbar onset] were included. All the topics covered in the recommendations were evaluated: diagnostic delay (e.g. mean 13.6 months, associated with age and onset); breaking the news (e.g. criteria for communication quality were satisfactory in more than 90%); multidisciplinary and sustained support (e.g. clinic visits were scheduled every 2-3 months in 90%). Also considered were whether riluzole had been offered, symptom management, genetic testing, ventilation, communication defects, enteral nutrition, palliative and end-of-life care. Characteristics associated with poor compliance with some guidelines (schedule of visits, delayed riluzole initiation) were also identified. ConclusionThis is the first evaluation of the application of the EFNS recommendations for the management of ALS in a nationwide sample. The results allow us to highlight areas for improvement.
引用
收藏
页码:787 / 795
页数:9
相关论文
共 50 条
  • [31] Bereitschaftspotential in amyotrophic lateral sclerosis (ALS): lower amplitudes in patients with hyperreflexia (spasticity)
    Westphal, KP
    Heinemann, HA
    Grozinger, B
    Kotchoubey, BJ
    Diekmann, V
    Becker, W
    Kornhuber, HH
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 98 (01): : 15 - 21
  • [32] Coping strategies among amyotrophic lateral sclerosis (ALS) patients: an integrative review
    Leandro, Georgiana Soares
    Dourado Junior, Mario Emilio Teixeira
    Santana, Glauciane Costa
    Dantas, Luan Samy Xavier
    JOURNAL OF NEUROLOGY, 2022, 269 (02) : 693 - 702
  • [33] Coping strategies among amyotrophic lateral sclerosis (ALS) patients: an integrative review
    Georgiana Soares Leandro
    Mário Emílio Teixeira Dourado Júnior
    Glauciane Costa Santana
    Luan Samy Xavier Dantas
    Journal of Neurology, 2022, 269 : 693 - 702
  • [34] Phase Angle and Bioelectrical Impedance Vector Analysis (BIVA) in Amyotrophic Lateral Sclerosis (ALS) Patients
    Cunha, Thais Alves
    Lopes, Marcia Marilia Gomes Dantas
    Brito, Acsa Nara de Araujo
    Vermeulen-Serpa, Karina Marques
    Vale, Sancha Helena de Lima
    Brandao-Neto, Jose
    Leite-Lais, Lucia
    APPLIED SCIENCES-BASEL, 2024, 14 (04):
  • [35] Diffusion tensor imaging biomarkers and clinical assessments in amyotrophic lateral sclerosis (ALS) patients: an exploratory study
    Pezeshgi, Saharnaz
    Ghaderi, Sadegh
    Mohammadi, Sana
    Karimi, Narges
    Ziaadini, Bentolhoda
    Mohammadi, Mahdi
    Fatehi, Farzad
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (09): : 5080 - 5090
  • [36] "Patients with amyotrophic lateral sclerosis (ALS) are usually nice persons"How physicians experienced in ALS see the personality characteristics of their patients
    Mehl, Theresa
    Jordan, Berit
    Zierz, Stephan
    BRAIN AND BEHAVIOR, 2017, 7 (01):
  • [37] Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study
    Shamshiri, Hosein
    Fatehi, Farzad
    Davoudi, Farnoush
    Mir, Elham
    Pourmirza, Behin
    Abolfazli, Roya
    Etemadifar, Masoud
    Harirchian, Mohammad Hossein
    Gharagozli, Koroush
    Ayromlou, Hormoz
    Basiri, Keivan
    Zamani, Babak
    Rohani, Mohammad
    Sedighi, Behnaz
    Roudbari, Ali
    Kasmaei, Hossein Delavar
    Nikkhah, Karim
    Naeini, Alireza Ranjbar
    Nafissi, Shahriar
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2015, 16 (7-8) : 506 - 511
  • [38] Advance care planning in amyotrophic lateral sclerosis (ALS): study protocol for a qualitative longitudinal study with persons with ALS and their family carers
    Vandenbogaerde, Isabel
    Miranda, Rose
    De Bleecker, Jan L.
    Carduff, Emma
    van der Heide, Agnes
    Van den Block, Lieve
    Deliens, Luc
    De Vleminck, Aline
    BMJ OPEN, 2022, 12 (05):
  • [39] Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)
    Guenther, Rene
    Suhr, Martin
    Koch, Jan C.
    Baehr, Mathias
    Lingor, Paul
    Toenges, Lars
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2012, (61):
  • [40] The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea
    Vogt, Susanne
    Schreiber, Stefanie
    Heinze, Hans-Jochen
    Dengler, Reinhard
    Petri, Susanne
    Vielhaber, Stefan
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2019, 17 (1)